Cofetuzumab Pelidotin
82930

TargetPTK7
Product group Antibodies
Overview
- SupplierBPS Bioscience
- Product NameCofetuzumab Pelidotin
- Delivery Days Customer23
- CertificationResearch Use Only
- ClonalityMonoclonal
- Estimated Purity≥90%
- Gene ID5754
- Target namePTK7
- Target descriptionprotein tyrosine kinase 7 (inactive)
- Target synonymsCCK4; CCK-4; colon carcinoma kinase 4; inactive tyrosine-protein kinase 7; pseudo tyrosine kinase receptor 7; PTK7 protein tyrosine kinase 7; tyrosine-protein kinase-like 7
- Protein IDQ13308
- Protein NameInactive tyrosine-protein kinase 7
- Scientific DescriptionCofetuzumab pelidotin (PF-06647020) is a PTK7-targeting ADC comprising a humanized anti-PTK7 mAb (hu6M024, IgG1) joined to an auristatin microtubule inhibitor payload, auristatin-0101 (Aur0101), by a cleavable valine-citrulline (vc)-based linker. Cofetuzumab pelidotin has a DAR of 4. Cofetuzumab pelidotin binds to cell-surface PTK7 with an EC50 of 1153 pM by flow cytometry. Cofetuzumab pelidotin has the potential for solid tumors research1,2,3.
- Storage Instruction-80°C
- UNSPSC12352203